The data could provide a road map for the 15 million people who received the Johnson & Johnson vaccine in the United States, many of whom have felt left out because the vast majority of U.S. vaccine recipients got Pfizer-BioNTech or Moderna.
Carolyn Y. Johnson, Washington Post
Wed, 10/13/2021 - 1:12pm